团队依托

京津神经免疫中心 / 神经免疫全国联盟

北京天坛医院(京津)神经免疫中心 集北京天坛医院和天津医科大学总医院之专长,竭诚为神经免疫和感染性疾病患者提供中国最好的临床诊治服务。京津神经免疫中心由著名临床神经免疫学家、国家“国家高层次人才”、“长江学者”、国家重大科学研究计划项目(973)首席科学家施福东教授领衔,包括北京天坛医院和天津医科大学总医院的临床专病门诊(年门诊量1000人)、病房(床位95张)、神经影像以及实验室单元。

京津共建神经免疫与感染疾病“国家队”

为深入贯彻落实国家创新驱动发展战略,促进产业结构转型升级,建设中国研究型医院,2018年2月25日,由首都医科大学附属北京天坛医院和天津医科大学总医院共同组建的京津神经免疫与感染疾病研究中心在北京天坛医院新址正式成立。中心旨在以其最先进的诊疗理念为我国神经免疫和感染性疾病患者提供最好的临床诊治服务,致力于攻克神经免疫病诊治的技术难题、并培养我国一流的临床神经免疫学家。

国际顾问委员会成员

International Advisory Board

Hans-Gustaf Ljunggren, MD PhD

Professor Hans-Gustaf Ljunggren earned his medical and doctoral degrees at Karolinska Institutet. In 2001, he was appointed Professor of Infection Medicine and Director of the Center for Infectious Medicine (CIM), a Strategic Research Center at the Department of Medicine, Karolinska Institutet. He has authored >300 articles within the fields of immunology, infectious diseases and cancer.

Professor Ljunggren has been member of the organizing or scientific committees of numerous international conferences. He has had multiple national and international assignments, involving external research evaluations and participation in international advisory boards. He has been the member of the editorial board of several leading international journals within the field of immunology. He is on the SAB and in other ways actively involved in several start up companies. He has functioned as Dean of Research at Karolinska Institutet and is member of the Nobel Assembly at Karolinska Institutet, which awards the Nobel Prize in Physiology or Medicine.

关闭
展开详情

Luc Van Kaer, MD PhD

Dr. Van Kaer received bachelor’s, master’s and PhD degrees from Ghent University in Belgium. His PhD studies focused on the molecular biology of bacteriophage that infect the Gram-positive bacterium Bacillus subtilis. He subsequently performed postdoctoral research in the laboratory of Nobel Laureate Dr. Susumu Tonegawa at the Massachusetts Institute of Technology (Cambridge, MA), where he investigated the immunological functions of gd T cells and the mechanisms of MHC class I-restricted antigen processing. In 1993, he joined the faculty at Vanderbilt University School of Medicine in Nashville (TN), where he continued his studies on MHC class I-restricted antigen presentation and expanded this work to include MHC class II-restricted antigen presentation and the immunological functions of non-classical MHC class I molecules such as CD1d, Qa-1 and the thymus leukemia (TL) antigen. His current research focuses on the interface between immune and metabolic responses, with an emphasis on the contribution of autophagy, an intracellular degradation system that delivers cytoplasmic constituents to lysosomes in response to nutrient deprivation, to various immune functions. Conversely, his lab is interested in the mechanisms by which immune cells control metabolic processes and disease. In these studies, his lab has employed a variety of experimental models of disease, including mouse models of autoimmune, inflammatory, vascular and metabolic disease.

关闭
展开详情

V. Wee Yong, MD PhD

Dr. V. Wee Yong is a Professor at the University of Calgary, Canada. He co-leads the Multiple Sclerosis (MS) NeuroTeam at the university and he directs the provincial Alberta MS Network. Dr. Yong’s research interests lie in the area of neuroimmunology, neuroprotection and CNS regeneration, and his projects are guided by MS and brain tumors. Dr. Yong has published 300 peer-reviewed manuscripts and his research has been translated into Phase III clinical trials in MS and spinal cord injury; he has just received national funding for a Phase I/IIa trial in glioblastoma. His work has been cited over 20,000 times (web of science; h-index of 80). Dr. Yong is a past chair of the Medical Advisory Committee of the MS Society of Canada, he sits on the editorial board of 7 international journals, and he is the Honorary Editor-in-Chief of the journal Neuroimmunology and Neuroinflammation. Dr. Yong has been the President of the International Society of Neuroimmunology (2014-2016) and he continues to co-direct its Global Schools of Neuroimmunology. Dr. Yong is an elected fellow of both the Canadian Academy of Health Sciences and the Royal Society of Canada. He is the 2017 Allyn Taylor International Prize in Medicine winner.

关闭
展开详情

Kazuo Fujihara, MD PhD

Kazuo Fujihara, M.D.is Professor, Department of Multiple Sclerosis Therapeutics, Fukushima Medical University School of Medicine, and Director, Multiple Sclerosis & Neuromyelitis Optica Center, Southern TOHOKU Research Institute for Neuroscience (STRINS), Koriyama, Japan. Dr. Fujihara is a neurologist and has mainly worked in the field of multiple sclerosis (MS), neuromyelitis optica (NMO) and related neuroimmunological disorders. He is a member of the International Panel on Diagnosis of MS (the 2010 and 2017 revisions to the McDonald Criteria) and the International Panel on NMO Diagnosis (the 2015 International Consensus Diagnostic Criteria of NMOSD). Since 2013, he has served on the Executive Committee, International Medical and Scientific Board of The Multiple Sclerosis International Federation (MSIF), and the Board of European Charcot Foundation (ECF). He is an inaugural member and President (2018~) of Pan-Asian Committee for Treatment and Research in Multiple Sclerosis (PACTRIMS).

关闭
展开详情

Prof. Richard Ransohoff, CCF 京津神经免疫中心联合会诊

Prof. Michael Chopp 京津神经免疫中心学术报告

Prof. Jeffrey L. Bennett 京津神经免疫中心报告

Gertrude Gilden Professor of Neurology and Ophthalmology

Dr. Deren Huang 京津神经免疫中心联合会诊

联系我们